Pulmotect, Inc.
  • Home
  • About Us
    • Our Company
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Our Approach
    • Overview
    • Our Science
    • Our Pipeline
    • Published Journal Articles
  • News
  • Contact Us

Safety, tolerability, and biomarkers of the treatment of mice with aerosolized Toll-like receptor ligands

Post navigation

Pneumonia during remission induction chemotherapy in patients with acute leukemia
Activation of lung toll-like receptors does not exacerbate sickness responses to lipopolysaccharide in mice Brain Behavior and Immunity
Pulmotect Inc

3900 Essex Ln, Suite 575
Houston, TX 77027
Contact Us

© 2025
Pulmotect, Inc.